Natural Molecules From Chinese Herbs Protecting Against Parkinson’s Disease via Anti-oxidative Stress

Natural Molecules From Chinese Herbs Protecting Against Parkinson’s Disease via Anti-oxidative Stress

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease, affecting about 7–10 million patients worldwide. The major pathological features of PD include loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain and th...

Full description

Bibliographic Details
Main Authors:	Yaqi Ding, Chenqi Xin, Cheng-Wu Zhang, Kah-Leong Lim, Hang Zhang, ZhenQian Fu, Lin Li, Wei Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson’s disease dopaminergic neurons oxidative stress natural molecules Chinese herb
Online Access:	https://www.frontiersin.org/article/10.3389/fnagi.2018.00246/full

Similar Items

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
by: Yee Jie Yeap, et al.
Published: (2023-01-01)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
by: Xuan He, et al.
Published: (2019-02-01)

Chemical and Biological Molecules Involved in Differentiation, Maturation, and Survival of Dopaminergic Neurons in Health and Parkinson’s Disease: Physiological Aspects and Clinical Implications
by: Giulia Gaggi, et al.
Published: (2021-06-01)

Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors
by: Hua Qin, et al.
Published: (2020-11-01)

Healing with Chinese herbs /
by: 345510 Tierra, Lesley Gunsaulus
Published: (1999)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01)

Roles of stem cells in the treatment of Parkinson's disease
by: Yasaman Ebrahimikia, et al.
Published: (2018-10-01)

Excessive Daytime Sleepiness in Parkinson’s Disease
by: Liu H, et al.
Published: (2022-09-01)

Current status of stem cell-derived therapies for Parkinson’s disease : from cell assessment and imaging modalities to clinical trials
by: Jang, Se Eun, et al.
Published: (2021)

Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01)

The healing power of Chinese herbs and medicinal recipes /
by: Hou, Joseph P., 1929-, et al.
Published: (2005)

A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
by: Giselle Prunell, et al.
Published: (2022-11-01)

Parkinson’s disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010-11-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
by: Xin He, et al.
Published: (2021-11-01)

Triggering Receptor Expressed on Myeloid Cells 2 Protects Dopaminergic Neurons by Promoting Autophagy in the Inflammatory Pathogenesis of Parkinson’s Disease
by: Wei Huang, et al.
Published: (2021-11-01)

The pharmacology of Chinese herbs /
by: Huang, K. C. (Kee Chang), 1917-, et al.
Published: (1999)

Brain‐derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease
by: E Chang, et al.
Published: (2021-08-01)

Advances of anti-glaucoma Chinese herb monomers
by: Wei Qin, et al.
Published: (2020-10-01)

Current review of Chinese medicine : quality control of herbs and herbal materials /
by: Leung, Ping-Chung, 1941-, et al.
Published: (2006)

Downregulation of Ambra1 by altered DNA methylation exacerbates dopaminergic neuron damage in a fenpropathrin-induced Parkinson-like mouse model
by: Songzhe He, et al.
Published: (2024-02-01)

Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
by: Longping Yao, et al.
Published: (2021-07-01)

The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
by: Viviana A. Ruiz-Pozo, et al.
Published: (2023-08-01)

Understanding miRNA Based Gene Regulation in Parkinson’s Disease: An in silico Approach
by: Surya Narayan Rath, et al.
Published: (2020-03-01)

Tonic Herbs and Herbal Mixtures in Chinese Medicine
by: Thomas Efferth, et al.
Published: (2016-01-01)

A novel curcumin oil solution can better alleviate the motor activity defects and neuropathological damage of a Parkinson’s disease mouse model
by: Xiwen Geng, et al.
Published: (2022-07-01)

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
by: Hanwen Zhang, et al.
Published: (2022-06-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson’s Disease Model
by: Ruru Jia, et al.
Published: (2023-02-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Research progress in the intervention of Chinese herb monomers on diabetic retinal neurodegeneration
by: Lu-Ping Liu, et al.
Published: (2023-04-01)

Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy
by: Khalid M. Alharthy, et al.
Published: (2024-02-01)

Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
by: Hye-Sun Lim, et al.
Published: (2019-11-01)

Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways
by: Jun Sung Park, et al.
Published: (2023-08-01)

Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice and Future Perspectives
by: Christopher Wai Kei Lam, et al.
Published: (2013-05-01)

Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
by: Elena A. Katunina, et al.
Published: (2023-01-01)

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson’s Disease
by: Christelle Lasbleiz, et al.
Published: (2019-02-01)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease
by: Julian L. Goggi, et al.
Published: (2020-08-01)

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease
by: Ramesh Pariyar, et al.
Published: (2022-02-01)